Alfasigma is a global pharmaceutical company founded almost 80 years ago in Italy, where it is headquartered (in Bologna and Milan). The Group operates in over 100 markets spanning Europe, North and South America, Asia, and Africa. It has offices in many countries, including Italy, the US, Spain, Germany, Mexico, and China; production sites in Italy (Pomezia, RM; Alanno, PE; Sermoneta, LT;), Spain (Tortosa, Baix Ebre), and the United States (Shreveport, Louisiana); and R&D labs in Italy (Pomezia and Bergamo). Alfasigma employs approximately 4,000 people dedicated to research, development, production, and distribution of medicinal products, contributing to its mission to provide better health and a better quality of life for patients, caregivers, and healthcare providers. It focuses on three main therapeutic areas: Gastroenterology, Vascular, and Rheumatology. Its portfolio spans from primary care to specialty care, rare disease medications, and consumer health products, including medical foods and nutraceuticals. Read here our social media netiquette: https://it.alfasigma.com/informative-privacy/netiquettesocialnetwork/
Looking for a particular Alfasigma employee's phone or email?
The Alfasigma annual revenue was $1.6 billion in 2026.
Francesco Balestrieri is the CEO of Alfasigma.
1,737 people are employed at Alfasigma.
Alfasigma is based in Bologna, Emilia-Romagna.
The NAICS codes for Alfasigma are [32541, 3254, 325, 32].
The SIC codes for Alfasigma are [283, 28].